ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
62 822,00
6,26%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Arch Therapeutics Inc (QB) (ARTH)

  7. Arch Therapeutics Inc (QB) (ARTH) Actualités

ARTH

Arch Therapeutics (QB) (ARTH)

Arch Therapeutics Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:ARTH
DateHeureSourceTitreSymboleSociété
22/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
23/05/202312h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
16/05/202312h01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARTHArch Therapeutics Inc (QB)
25/01/202321h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARTHArch Therapeutics Inc (QB)
23/01/202323h18Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
28/12/202222h52Edgar (US Regulatory)Annual Report (10-k)USOTC:ARTHArch Therapeutics Inc (QB)
31/08/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202223h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202212h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ARTHArch Therapeutics Inc (QB)
22/08/202212h04Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARTHArch Therapeutics Inc (QB)
18/08/202212h03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ARTHArch Therapeutics Inc (QB)
17/08/202222h11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ARTHArch Therapeutics Inc (QB)
15/08/202222h24Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
08/07/202223h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
22/03/202210h14TipRanksDawson James Remains a Buy on Arch Therapeutics (ARTH)USOTC:ARTHArch Therapeutics Inc (QB)
04/01/202222h18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ARTHArch Therapeutics Inc (QB)
28/12/202122h06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ARTHArch Therapeutics Inc (QB)
22/12/202122h08Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ARTHArch Therapeutics Inc (QB)
25/02/202118h27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ARTHArch Therapeutics Inc (QB)
17/10/201923h11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:ARTHArch Therapeutics Inc (QB)
20/07/201819h15Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ARTHArch Therapeutics Inc (QB)
17/11/201619h35Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201622h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:ARTHArch Therapeutics Inc (QB)
16/07/201614h00InvestorsHub NewsWireInsider Financial Publishes New Research On Three Promising BiotechsUSOTC:ARTHArch Therapeutics Inc (QB)
14/07/201614h33InvestorsHub NewsWireOne Step Vending Corp. KOSK – 230% Growth and Over 150,000 Units SuppliedUSOTC:ARTHArch Therapeutics Inc (QB)
14/10/201512h03Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARTHArch Therapeutics Inc (QB)
16/06/201414h15MarketwiredArch Therapeutics Co-Founder Rutledge Ellis-Behnke to Speak at European Summit for Clinical Nanomedicine & Targeted Medicine ...USOTC:ARTHArch Therapeutics Inc (QB)
28/05/201415h00MarketwiredArch Therapeutics Inc. to Present at the LD MICRO Invitational 2014 on June 4thUSOTC:ARTHArch Therapeutics Inc (QB)
27/05/201415h00MarketwiredArch Therapeutics Inc. to Present at the Third Annual Marcum MicroCap ConferenceUSOTC:ARTHArch Therapeutics Inc (QB)
01/04/201414h00MarketwiredArch Therapeutics Appoints Chirag Shah, PhD as Vice President of R&D Engineering & Quality Systems & Peter LaCrosse as Chief ...USOTC:ARTHArch Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:ARTH

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
NYSE
DIS
Walt Disney
EU
PX1
CAC 40
SPI
SP500
S&P 500
NYSE
JPM
JP Morgan Chase
EU
CS
Axa
EU
RNO
Renault
NYSE
MRK
Merck
EU
MC
Lvmh Moet Hennessy Louis...
EU
PX4
SBF 120
NASDAQ
MSFT
Microsoft
EU
CAP
Capgemini
EU
SGO
Cie de SaintGobain
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés